Logo for Nektar Therapeutics

Nektar Therapeutics Investor Relations Material

Latest events

Logo for Nektar Therapeutics

Study Update

Nektar Therapeutics
Logo for Nektar Therapeutics

Study Update

24 Jun, 2025
Logo for Nektar Therapeutics

Q1 2025

8 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Nektar Therapeutics

Access all reports
Nektar Therapeutics is an American biopharmaceutical company that specializes in the discovery and development of novel therapies. These therapies aim to selectively modulate the immune system to treat autoimmune disorders, chronic inflammatory conditions, and cancer.The company uses proprietary PEGylation and advanced polymer conjugate technologies to modify the chemical structure of substances, facilitating the development of new drug candidates. It is headquartered in San Francisco, California, and its shares are listed on the NASDAQ under the ticker symbol NKTR.